Aignostics launches HETA Clinical for pathology workflows

Aignostics announced in a press release HETA Clinical, a family of AI products for pathology workflows and molecular testing. The first four products analyze whole slide H&E images across multiple cancer types.

HETA Quality Control identifies slide quality issues before analysis. HETA Tumor Detect marks tumor regions and flags scans likely to contain tumor, while HETA Mitosis counts mitoses. HETA Tumor Cellularity measures tumor cell content and selects a region with enough tumor content for molecular testing.

The products use HETA, formerly called Atlas H&E TME, Aignostics' platform for spatial tissue analysis. Aignostics plans to add more HETA Clinical products and integrate them with image management systems, including Techcyte Fusion AP. The four initial products are for research use only and not for use in diagnostic procedures.